Ketamine-Assisted Psychotherapy: New Insights from APA 2025
As treatment-resistant depression (TRD) challenges traditional psychiatric models, interest is growing in ketamine-assisted psychotherapy (KAP)—a blend of pharmacological intervention and therapeutic support. At the 2025 American Psychiatric Association (APA) Annual Meeting, Dr. Fernando Espí Forcén offered updated insights into KAP’s evolving role in psychiatric care.
